Moving into the pandemic’s third year, as many settle into the notorious “new normal” of COVID, the challenge now is avoiding complacency and keeping attention and vaccination rates high enough to maintain protection against the still-evolving virus. Six months after approving a first vaccine booster, the FDA has now authorized a second booster dose for
Done with COVID? Not so fast. originally appeared in KevinMD.com.
